Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

Solventum Corp

ClinicalTrials.gov lists Solventum Corp as lead sponsor of 93 trials, counting the companies grouped under it.

US Industry Manufacturer CIK 0001964738
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 6 Related companies not grouped here Related companies not grouped here 1 Disease areas Disease areas 2 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Journals published in Journals published in 16 SEC-reported annual financials SEC-reported annual financials 5 Financing and grant events Financing and grant events 12 Climate targets, as filed Climate targets, as filed 1 Companies grouped under this page Companies grouped under this page 6 Related companies not grouped here Related companies not grouped here 1 Disease areas Disease areas 2 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Journals published in Journals published in 16 SEC-reported annual financials SEC-reported annual financials 5 Financing and grant events Financing and grant events 12 Climate targets, as filed Climate targets, as filed 1

Rows recorded per section

2 more sections with rows · 14 sections measured, none recorded

Logo Solventum, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers Solventum Corp and 6 companies grouped under it: 93 lead-sponsored trials (0 its own, 93 in the grouped companies) and 5 legal-entity registrations (2 its own, 3 in the grouped companies).

Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.

Get the Solventum Corp report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (6)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Lead trials Legal entities
SOLVENTUM US LLC 64 2
KCI USA, Inc 18 0
Acera Surgical, Inc. 5 0
Systagenix Wound Management 4 0
Solventum Orthodontics Corporation 2 0

Showing 5 of 6 member companies.

Start your 14-day trial Email me all 6 member companies as a PDF

Disease areas (2)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Dentin Sensitivity 1
Sarcoma 1

Trials by start year as sponsor or collaborator (1)

Trials by start year as sponsor or collaborator
Year Trials started
2025 2

No forecast is made for this organization: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Journals published in (16)

Shown in this order: most published in first.

Journals published in
Journal Publications
Annals of the Royal College of Surgeons of England 1
BMC oral health 1
Bone & joint open 1
Brazilian dental journal 1
Caries research 1

Showing 5 of 16 journals.

Start your 14-day trial Email me all 16 journals as a PDF

SEC-reported annual financials (5)

Shown in this order: newest fiscal year first; SEC EDGAR XBRL companyfacts, USD as reported.

SEC-reported annual financials
Fiscal year Revenue (USD) Net income (USD) R&D (USD)
2025 8,325,000,000 1,556,000,000 739,000,000
2024 8,254,000,000 479,000,000 775,000,000
2023 8,197,000,000 1,346,000,000 758,000,000
2022 8,130,000,000 1,343,000,000 767,000,000
2021 not reported not reported not reported

Financing and grant events (12)

Shown in this order: most recent first.

Financing and grant events
Date Round type Amount (USD) Source
2025-09-08 Debt financing not disclosed Sec extracted
2025-09-01 Other financing 4,000,000,000 Sec extracted
2025-08-22 Debt financing not disclosed Sec extracted
2025-08-14 Other financing not disclosed Edgar offerings
2025-08-14 Other financing not disclosed Edgar offerings

Showing 5 of 12 events.

Start your 14-day trial Email me all 12 events as a PDF

Climate targets, as filed (1)

Climate targets, as filed
Reporting year Net-zero target
2025 not disclosed

Workforce and board diversity, as filed (1)

Workforce and board diversity, as filed
Reporting year Workforce % women Board % women
2025 not disclosed not disclosed

Latest dated events (14)

Shown in this order: newest first.

Latest dated events
Date Event Source
2025-12-04 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-12-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-09-08 Debt facility Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2025-09-01 Financing Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2025-08-22 Debt facility Funding rounds and grants (NIH RePORTER + SEC EDGAR)

Showing 5 of 14 events.

Start your 14-day trial Email me all 14 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: active development programs, approved assets, sponsor delivery record, us granted patents, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.